Fogchain Corp, based in San Carlos, CA, is the parent company of Allora, a groundbreaking medical diagnostics company. Allora is currently in the late-stage clinical development of the Allora BreathTest, a rapid test that can detect lung bacterial infections in just 10 minutes. This innovative breath test has the potential to differentiate between different types of lung infections, providing valuable information for effective treatment.
Allora's Allora BreathTest is a value-based and cost-advantaged product that aims to benefit patients, doctors, hospitals, and payers. With a focus on clinical applications, Allora is actively involved in research and development for various respiratory conditions, including ventilator-associated pneumonia, post-Covid-19 bronchiectasis, chronic obstructive pulmonary disease, community-acquired pneumonia, cystic fibrosis, tuberculosis, aspergillus coccii fungus, and clostridium difficile. Through their groundbreaking technology, Allora is poised to revolutionize the diagnosis and monitoring of pulmonary infections.
Generated from the website